Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines - PubMed (original) (raw)

Practice Guideline

. 2008 Jun 15;111(12):5446-56.

doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23.

Collaborators, Affiliations

• PMID: 18216293
• PMCID: PMC2972576
• DOI: 10.1182/blood-2007-06-093906

Practice Guideline

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Michael Hallek et al. Blood. 2008.

Erratum in

• Blood. 2008 Dec 15;112(13):5259

Abstract

Standardized criteria for diagnosis and response assessment are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies. Therefore, a National Cancer Institute-sponsored Working Group (NCI-WG) on chronic lymphocytic leukemia (CLL) published guidelines for the design and conduct of clinical trials for patients with CLL in 1988, which were updated in 1996. During the past decade, considerable progress has been achieved in defining new prognostic markers, diagnostic parameters, and treatment options. This prompted the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) to provide updated recommendations for the management of CLL in clinical trials and general practice.

PubMed Disclaimer

Comment in

• The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences?
  Hanson CA, Kurtin PJ, Dogan A. Hanson CA, et al. Blood. 2009 Jun 18;113(25):6495-6. doi: 10.1182/blood-2008-05-158444. Blood. 2009. PMID: 19541837 No abstract available.
• Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL).
  Mulligan CS, Thomas ME, Mulligan SP. Mulligan CS, et al. Blood. 2009 Jun 18;113(25):6496-7; author reply 6497-8. doi: 10.1182/blood-2008-07-166710. Blood. 2009. PMID: 19541838 No abstract available.
• Clearly defined response criteria evaluating treatment of CLL patients in clinical research trials.
  Foon KA. Foon KA. Blood. 2010 Sep 9;116(10):1817; author reply 1817-8. doi: 10.1182/blood-2010-03-274035. Blood. 2010. PMID: 20829381 No abstract available.
• Microvesicles in chronic lymphocytic leukemia: ready for prime time in the clinic?
  Handunnetti SM, Polliack A, Tam CS. Handunnetti SM, et al. Leuk Lymphoma. 2017 Jun;58(6):1281-1282. doi: 10.1080/10428194.2017.1298756. Leuk Lymphoma. 2017. PMID: 28271951 No abstract available.

Similar articles

• Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).
  Eichhorst B, Hallek M. Eichhorst B, et al. Best Pract Res Clin Haematol. 2007 Sep;20(3):469-77. doi: 10.1016/j.beha.2007.02.002. Best Pract Res Clin Haematol. 2007. PMID: 17707834
• Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
  Call TG, Norman AD, Hanson CA, Achenbach SJ, Kay NE, Zent CS, Ding W, Cerhan JR, Rabe KG, Vachon CM, Hallberg EJ, Shanafelt TD, Slager SL. Call TG, et al. Cancer. 2014 Jul 1;120(13):2000-5. doi: 10.1002/cncr.28690. Epub 2014 Apr 7. Cancer. 2014. PMID: 24711224 Free PMC article.
• Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.
  Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G, Döhner H, Hallek M, Hillmen P, Keating M, Montserrat E, Kipps TJ, Rai K; International Workshop on Chronic Lymphocytic Leukemia (IWCLL). Binet JL, et al. Blood. 2006 Feb 1;107(3):859-61. doi: 10.1182/blood-2005-04-1677. Epub 2005 Oct 13. Blood. 2006. PMID: 16223776 Review.
• SOHO State of the Art Updates and Next Questions: The Conundrum in Assessing the Therapy Response of Patients With Chronic Lymphocytic Leukemia.
  Choi MY, Wang HY, Kipps TJ. Choi MY, et al. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):321-325. doi: 10.1016/j.clml.2019.05.013. Epub 2019 May 29. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31204237 Review.

Cited by

• Safety of different amphotericin B formulations among AIDS patients with invasive fungal disease: a retrospective observational study.
  Tan Y, Mo Y, Wu S, Tan M, Song S, Liu J, Yu H, Liang K. Tan Y, et al. AIDS Res Ther. 2024 Sep 29;21(1):66. doi: 10.1186/s12981-024-00649-w. AIDS Res Ther. 2024. PMID: 39343879 Free PMC article.
• Leukemia in pregnancy: Diagnosis and therapeutic approach (Review).
  Giannakaki AG, Giannakaki MN, Oikonomou E, Nikolettos K, Bothou A, Kotanidou S, Andreou S, Kritsotaki N, Nalmpanti T, Spanoudakis E, Iatrakis G, Damaskos C, Garmpis N, Nikolettos N, Tsikouras P. Giannakaki AG, et al. Mol Clin Oncol. 2024 Aug 21;21(5):79. doi: 10.3892/mco.2024.2777. eCollection 2024 Nov. Mol Clin Oncol. 2024. PMID: 39246846 Free PMC article. Review.
• Global burden, risk factor analysis, and prediction study of leukaemia from 1990 to 2030.
  Wang W, Zhang D, Liang Q, Liu X, Shi J, Zhou F. Wang W, et al. J Glob Health. 2024 Aug 23;14:04150. doi: 10.7189/jogh.14.04150. J Glob Health. 2024. PMID: 39173170 Free PMC article.
• Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial.
  Guièze R, Ysebaert L, Roos-Weil D, Fornecker LM, Ferrant E, Molina L, Aurran T, Clavert A, de Guibert S, Michallet AS, Saad A, Drénou B, Quittet P, Hivert B, Laribi K, Gay J, Quinquenel A, Broseus J, Rouille V, Schwartz D, Magnin B, Lazarian G, Véronèse L, de Antonio M, Laurent C, Tournilhac O, Pereira B, Feugier P. Guièze R, et al. Nat Commun. 2024 Aug 9;15(1):6822. doi: 10.1038/s41467-024-51264-2. Nat Commun. 2024. PMID: 39122717 Free PMC article. Clinical Trial.
• Evaluation of the Findings of Peripheral Blood Smear, Bone Marrow Aspiration and Biopsy, Iron Storage, and Immunophenotype in Patients with Chronic Lymphocytic Leukemia.
  Didehban S, Jafari E, Hosseini A, Khorasani P. Didehban S, et al. Iran J Pathol. 2024 Spring;19(2):152-159. doi: 10.30699/IJP.2024.2011275.3170. Epub 2024 Jan 29. Iran J Pathol. 2024. PMID: 39118798 Free PMC article.

References

1. 1. Cheson BD, Bennett JM, Rai KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia (CLL): recommendations of the NCI-sponsored working group. Am J Hematol. 1988;29:153–163. - PubMed
2. 1. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 1996;87:4990–4997. - PubMed
3. 1. Müller-Hermelink HK, Montserrat E, Catovsky D, Harris NL. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. pp. 127–130.
4. 1. Catovsky D, Ralfkiaer E, Müller-Hermelink HK. T-cell prolymphocytic leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. pp. 195–196.
5. 1. Melo JV, Catovsky D, Galton DAG. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: IV. Analysis of survival and prognostic features. Br J Haematol. 1986;63:377–387. - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Miscellaneous

  • NCI CPTAC Assay Portal